Over the past nine months, more than $7 billion in federal funding has poured into the BioHealth Capital Region aimed at the battle against COVID-19 and has shown a spotlight on the broad impact biopharma life science companies and academic institutions are making in the fight against the pandemic.
Graybug Vision files for $86 Million IPO on NASDAQ (GRAY)
Johns Hopkins University’s Biomedical Careers Initiative, a Robust Ph.D. Talent Pipeline for the Region’s Life Science Industry
For Ph.D. students, deciding to leave the familiar environment of academia to pursue a career in the industry can be daunting. Often, Ph.D. students are so engrossed in their academic work they are simply unsure of what non-academic opportunities are out there and don’t know how to explore or test these options.
Nick Fullenkamp Appointed Chief Business Officer at Avidea Technologies, Inc. Nick Fullenkamp, M.B.A. has joined Avidea Technologies as Chief Business Officer and will be leading Business Development, financing strategy and [….]
Healthcare Systems Rise Up to Develop Innovative Solutions to COVID-19 Testing Shortages The availability of reliable, high-quality testing and the capacity to turn around results quickly remain two areas of [….]
Six Johns Hopkins COVID-19 Programs that Reflect A Culture of Leadership from Clinical Research to Healthcare Innovation